Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH)

Abstract

The timing cannot be more opportune, with therapeutic targets identified, exceptional collaboration among researchers and the patient community, along with several drugs ready to benefit from development of a path to clinical testing using this network in the next 5 years.